Method and System for Assessing Drug Efficacy Using Multiple Graph Kernel Fusion
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application 62/930,072, filed Nov 4, 2019. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,238,966 | Method and System for Assessing Drug Efficacy Using Multiple Graph Kernel Fusion In force · High confidence | Georgetown University | In force | High confidence | ||
| US 11,410,763 | Method and System for Assessing Drug Efficacy Using Multiple Graph Kernel Fusion In force · High confidence | Georgetown University | In force | High confidence | ||
| US 11,869,664 | Method and System for Assessing Drug Efficacy Using Multiple Graph Kernel Fusion In force · High confidence | Georgetown University | In force | High confidence | ||
| US 12,211,623 | Method and System for Assessing Drug Efficacy Using Multiple Graph Kernel Fusion In force · High confidence | Georgetown University | In force | High confidence | ||
| US 12,482,568 | Method and System for Assessing Drug Efficacy Using Multiple Graph Kernel Fusion In force · High confidence | Georgetown University | In force | High confidence | ||
| Application 19/373,285 | Cohort Selection for Treatment Evaluation Pending Not granted | Georgetown University | Pending | Not granted |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Georgetown University.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.